Group B Streptococcus
Cepheid Nabs FDA Clearance for Molecular Group B Strep Test
The Xpert Xpress assay is a dual-target PCR test intended for the qualitative intrapartum detection of group B Streptococcus.
Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases.
Hologic Acquires European MDx Firm Diagenode for Approximately $159M
Hologic said that the transaction further strengthens its molecular diagnostics business by expanding its international capabilities, among other benefits.
Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M
In 2018 Qiagen purchased a 19.9 percent stake in Ann Arbor, Michigan-based NeuMoDx along with the right to acquire the remaining shares.
The firm aims to stabilize and protect its existing molecular diagnostics business over the next 12 to 18 months, CEO Jack Kenny said.
Jun 19, 2014
Nov 21, 2013
Mar 7, 2013
Sep 27, 2012
Mar 29, 2012
Mar 28, 2012
BD Gets FDA OK for Group B Strep MDx Assay
Dec 12, 2011
FDA Clears Meridian's MDx Test for Group B Strep
Aug 5, 2010